Max Healthcare to host investor conference at J.P. Morgan event
NiveshIQ
NSE: MAXHEALTH · Healthcare
Max Healthcare Institute Ltd.
₹1,037.70▼ ₹0.90 (-0.09%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on MAXHEALTH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Max Healthcare Institute Ltd.
Max Healthcare Institute Limited operates a diversified network of multi‑specialty hospitals, primary care clinics, and diagnostic labs across India, generating ₹8,712 crore in FY25 revenue and ₹1,457 crore net income. Core revenue drivers include high‑margin specialty services such as cardiac, oncology, and organ transplant, which together account for roughly 45% of total earnings. The company has recently expanded its footprint by acquiring a 66.15% stake in Kalinga Hospital for ₹87.87 crore, strengthening its presence in the eastern market. Max@Home and Max Lab platforms have broadened the firm’s service mix, contributing an estimated 12% of revenue growth through at‑home care and diagnostic testing. Competitive positioning is reinforced by a robust referral network and a focus on techn
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹5,406 Cr +18.50% | ₹7,028 Cr +30.00% | ₹8,373 Cr +19.10% |
| EBITDA Margin | 27.60% | 26.31% | 28.73% |
| Net Profit | ₹1,058 Cr -4.20% | ₹1,076 Cr +1.70% | ₹1,491 Cr +38.50% |
| EPS | ₹10.88 | ₹11.07 | ₹14.83 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Max Healthcare to participate in Jefferies' 5th India Forum 2026
Max Healthcare to host investor conference at J.P. Morgan event
🔒
+ 3 more stories about Max Healthcare Institute Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹236, 617 Cr, PAT ₹32, 296 Cr, EPS ₹3.32, EBITDA margin 27.0%. Growth context: revenue QoQ +10942.0%, PAT QoQ +9337.2%. Street verdict: strong beat, revenue surprise +8480.4%, PAT surprise +7617.3%.
Management highlights new capacity addition and capex deployment as the primary near‑term growth lever, with execution o...
FY26 (last completed FY): revenue ₹8, 373 Cr, PAT ₹1, 491 Cr, EBITDA margin 28.7%, EPS ₹14.83. Year-on-year: revenue YoY...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for MAXHEALTH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track MAXHEALTH alongside your other holdings
Unlock full MAXHEALTH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Max Healthcare Institute Ltd.?
NiveshIQ detects active intelligence signals for Max Healthcare Institute Ltd. (MAXHEALTH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Max Healthcare Institute Ltd.?
Max Healthcare Institute Ltd. operates in the Healthcare sector with a market capitalisation of ₹10,619,062.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.